Clinical trial
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy…
NCT00078923 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00078923 |
|---|---|
| Title | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate |
| Official title | Phase II Clinical Trial of Soy Isoflavones Prior to Radical Prostatectomy |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Other, Procedure |
| Interventions | soy isoflavones, neoadjuvant therapy, Placebo |
| Enrollment | 32 |
| Start date | Nov 1, 2001 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 9, 2004 |
| Last update posted | Mar 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: